A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
PHIBRO ANIMAL HEALTH CORP
PAHC
$1.4B
Mkt Cap
$34.03
-0.01%
PHIBRO ANIMAL HEALTH CORP (PAHC) has a current P/E ratio of 15.1, compared to its historical median P/E of 19.6. The stock is currently considered Cheap based on its historical valuation range.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a 5-year average return on invested capital (ROIC) of 10.4%. This indicates solid capital allocation.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a market capitalization of $1.4B. It is classified as a small-cap stock.
Yes, PHIBRO ANIMAL HEALTH CORP (PAHC) pays a dividend with a trailing twelve-month yield of 1.40%.
Based on historical P/E analysis, PHIBRO ANIMAL HEALTH CORP (PAHC) appears cheap. The current P/E of 15.1 is 23% below its historical median of 19.6. The estimated fair value CAGR (P/E method) is -10.9%.
PHIBRO ANIMAL HEALTH CORP (PAHC) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
PHIBRO ANIMAL HEALTH CORP (PAHC) reported annual revenue of $1.3 billion in its most recent fiscal year, based on SEC EDGAR filings.
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 800 product lines in approximately 90 countries to approximately 4,500 customers. We develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through animal feed manufacturers, wholesalers, distributors and veterinarians.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.3B | 1.0B | 978M | 942M | 833M |
| Net Income | 95M | 48M | 2.4M | 33M | 49M | 54M |
| EPS | $2.33 | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 |
| Free Cash Flow | 13M | 42M | 46M | -38M | -5.4M | 19M |
| ROIC | 13.0% | 10.8% | 6.4% | 8.7% | 11.4% | 15.1% |
| Gross Margin | 32.5% | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% |
| Debt/Equity | 2.03 | 2.73 | 1.22 | 1.18 | 1.10 | 1.25 |
| Dividends/Share | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 |
| Operating Income | 180M | 110M | 53M | 72M | 79M | 75M |
| Operating Margin | 12.0% | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% |
| ROE | 26.3% | 17.8% | 0.9% | 12.0% | 19.6% | 25.5% |
| Shares Outstanding | 41M | 41M | 40M | 40M | 41M | 41M |
| Metric | 2017 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 692M | 749M | 752M | 764M | 820M | 828M | 800M | 833M | 942M | 978M | 1.0B | 1.3B | 1.5B |
| Gross Margin | 29.5% | 31.2% | 31.8% | 32.5% | 32.5% | 32.0% | 32.1% | 32.6% | 30.3% | 30.5% | 30.8% | 30.9% | 32.5% |
| R&D | 8.2M | 9.5M | 11M | 9.4M | 10.0M | 12M | 14M | 18M | 21M | 24M | 29M | 24M | 24M |
| SG&A | 141M | 146M | 153M | 150M | 168M | 181M | 188M | 197M | 206M | 226M | 260M | 289M | 308M |
| EBIT | 64M | 88M | 86M | 98M | 99M | 83M | 69M | 75M | 79M | 72M | 53M | 110M | 180M |
| Op. Margin | 9.2% | 11.7% | 11.4% | 12.8% | 12.1% | 10.1% | 8.6% | 9.0% | 8.4% | 7.3% | 5.2% | 8.5% | 12.0% |
| Net Income | -3.1M | 60M | 83M | 65M | 65M | 55M | 34M | 54M | 49M | 33M | 2.4M | 48M | 95M |
| Net Margin | -0.5% | 8.1% | 11.0% | 8.5% | 7.9% | 6.6% | 4.2% | 6.5% | 5.2% | 3.3% | 0.2% | 3.7% | 6.3% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 425K | 0 | 0 | 0 | 366K | 5.3M | 5.3M |
| Returns on Capital | |||||||||||||
| ROIC | 15.5% | 23.1% | 27.2% | 22.9% | 21.0% | 16.6% | 11.9% | 15.1% | 11.4% | 8.7% | 6.4% | 10.8% | 13.0% |
| ROE | 11.6% | 269.2% | 137.8% | 53.5% | 38.6% | 27.3% | 16.6% | 25.5% | 19.6% | 12.0% | 0.9% | 17.8% | 26.3% |
| ROA | -0.7% | 12.5% | 15.0% | 10.5% | 10.0% | 7.8% | 4.4% | 6.7% | 5.5% | 3.4% | 0.2% | 4.1% | 6.6% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -712K | 69M | 37M | 98M | 70M | 47M | 59M | 48M | 32M | 13M | 88M | 80M | 66M |
| Free Cash Flow | -21M | 49M | 866K | 78M | 51M | 17M | 25M | 19M | -5.4M | -38M | 46M | 42M | 13M |
| Owner Earnings | -22M | 46M | 13M | 72M | 43M | 17M | 25M | 15M | -1.1M | -21M | 51M | 34M | 14M |
| CapEx | 20M | 20M | 36M | 21M | 19M | 30M | 34M | 29M | 37M | 52M | 41M | 38M | 53M |
| Maint. CapEx | 21M | 22M | 23M | 26M | 27M | 28M | 32M | 32M | 33M | 34M | 36M | 46M | 51M |
| Growth CapEx | 0 | 0 | 13M | 0 | 0 | 2.3M | 1.7M | 0 | 4.3M | 18M | 5.1M | 0 | 2.8M |
| D&A | 21M | 22M | 23M | 26M | 27M | 28M | 32M | 32M | 33M | 34M | 36M | 46M | 51M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 63.4% | 57.4% | 60.7% | 117.0% | 389.1% | 47.1% | 47.8% | 80.7% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 25M | 16M | 16M | 16M | 16M | 19M | 19M | 19M | 19M | 19M | 19M | 19M | 19M |
| Dividend Yield | 5.3% | 1.7% | 1.6% | 1.7% | 1.2% | 1.5% | 2.2% | 2.4% | 2.5% | 3.5% | 3.8% | 2.3% | 1.4% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 73K | 1.4M | 1.0M | 0 | 334K | 2.3M | 2.3M | 1.1M | 0 | 0 | 475K | 717K | 1.4M |
| Debt Repayment | 335M | 35M | 190M | 286M | 220M | 187M | 170M | 392M | 247M | 268M | 241M | 621M | 621M |
| Balance Sheet | |||||||||||||
| Net Debt | 278M | 261M | 251M | 194M | 165M | 150M | 127M | 205M | 197M | 253M | 197M | 703M | 658M |
| Cash & Equiv. | 12M | 29M | 34M | 56M | 29M | 58M | 36M | 50M | 74M | 41M | 71M | 68M | 77M |
| Long-Term Debt | 286M | 287M | 284M | 250M | 244M | 231M | 219M | 298M | 273M | 312M | 282M | 650M | 598M |
| Debt/Equity | 19.10 | 9.79 | 3.14 | 1.65 | 1.32 | 1.07 | 1.16 | 1.25 | 1.10 | 1.18 | 1.22 | 2.73 | 2.03 |
| Interest Coverage | 2.1 | 6.0 | 5.1 | 5.8 | 7.3 | 6.1 | 4.7 | 5.5 | 6.2 | 3.8 | 2.3 | 3.0 | 261.2 |
| Equity | 15M | 30M | 90M | 151M | 185M | 216M | 188M | 239M | 262M | 283M | 257M | 286M | 362M |
| Total Assets | 472M | 493M | 608M | 623M | 672M | 727M | 784M | 841M | 932M | 971M | 982M | 1.4B | 1.4B |
| Total Liabilities | 457M | 464M | 517M | 472M | 487M | 511M | 596M | 603M | 669M | 689M | 726M | 1.1B | 1.1B |
| Intangibles | 30M | 37M | 60M | 55M | 52M | 47M | 71M | 62M | 64M | 55M | 45M | 36M | 32M |
| Retained Earnings | -97M | -37M | 34M | 83M | 132M | 169M | 183M | 218M | 248M | 261M | 244M | 273M | 336M |
| Working Capital | 187M | 202M | 234M | 248M | 272M | 312M | 295M | 335M | 375M | 410M | 397M | 517M | 612M |
| Current Assets | 299M | 314M | 343M | 364M | 415M | 466M | 452M | 499M | 566M | 586M | 601M | 811M | 894M |
| Current Liabilities | 112M | 111M | 109M | 116M | 143M | 154M | 157M | 164M | 191M | 176M | 204M | 293M | 282M |
| Per Share Data | |||||||||||||
| EPS | -0.10 | 1.51 | 2.07 | 1.61 | 1.61 | 1.35 | 0.83 | 1.34 | 1.21 | 0.81 | 0.06 | 1.19 | 2.33 |
| Owner EPS | -0.71 | 1.15 | 0.32 | 1.80 | 1.06 | 0.43 | 0.61 | 0.38 | -0.03 | -0.51 | 1.27 | 0.83 | 0.35 |
| Book Value | 0.48 | 0.74 | 2.26 | 3.77 | 4.59 | 5.33 | 4.66 | 5.88 | 6.46 | 7.02 | 6.37 | 7.04 | 8.83 |
| Cash Flow/Share | -0.02 | 1.72 | 0.93 | 2.45 | 1.74 | 1.16 | 1.47 | 1.19 | 0.78 | 0.33 | 2.18 | 1.98 | 3.56 |
| Dividends/Share | 0.82 | 0.40 | 0.40 | 0.40 | 0.40 | 0.46 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Shares Out. | 31.3M | 39.9M | 40.0M | 40.1M | 40.3M | 40.5M | 40.4M | 40.6M | 40.6M | 40.3M | 40.3M | 40.6M | 41.0M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | 20.0 | 26.5 | 19.1 | 14.4 | 15.5 | 272.0 | 21.4 | 14.6 |
| P/FCF | N/A | 24.3 | 696.2 | 16.4 | 30.0 | 63.4 | 35.1 | 54.8 | N/A | N/A | 14.2 | 24.7 | 109.1 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | 12.6 | 12.3 | 14.1 | 9.8 | 8.5 | 14.6 | 9.6 | 11.4 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | 5.1 | 4.7 | 4.4 | 2.7 | 1.8 | 2.6 | 3.6 | 3.9 |
| Price/Sales | 0.9 | 1.2 | 1.3 | 1.8 | 2.4 | 1.5 | 1.1 | 1.0 | 0.8 | 0.6 | 0.5 | 0.7 | 0.9 |
| FCF Yield | -3.2% | 4.2% | 0.1% | 6.1% | 3.3% | 1.6% | 2.8% | 1.8% | -0.8% | -7.6% | 7.1% | 4.0% | 0.9% |
| Market Cap | 649M | 1.2B | 594M | 1.3B | 1.6B | 1.1B | 888M | 1.0B | 706M | 506M | 657M | 1.0B | 1.4B |
| Avg. Price | 15.07 | 22.80 | 24.07 | 22.66 | 32.19 | 31.17 | 21.43 | 19.57 | 19.04 | 13.94 | 12.80 | 21.24 | 34.03 |
| Year-End Price | 16.48 | 29.67 | 15.09 | 31.62 | 38.33 | 27.02 | 21.98 | 25.66 | 17.38 | 12.57 | 16.32 | 25.51 | 34.03 |
PHIBRO ANIMAL HEALTH CORP passes 3 of 9 quality checks, indicating weak fundamentals.
PHIBRO ANIMAL HEALTH CORP trades at 15.1x trailing earnings, compared to its 15-year median P/E of 19.6x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 14.8x vs a median of 30.0x. The company's 5-year average ROIC is 10.4% with a gross margin of 31.0%. Total shareholder yield (dividends) is 1.4%. At current prices, the estimated annualized return to fair value is +30.0%.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a net profit margin of 3.7%. This is a modest margin.
PHIBRO ANIMAL HEALTH CORP (PAHC) generated $42 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a debt-to-equity ratio of 2.73. This indicates higher leverage, which may increase financial risk.
PHIBRO ANIMAL HEALTH CORP (PAHC) reported earnings per share (EPS) of $1.19 in its most recent fiscal year.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a return on equity (ROE) of 17.8%. This indicates the company generates strong returns for shareholders.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a 5-year average gross margin of 31.0%. This indicates decent pricing power.
The Ledger Terminal provides 14 years of financial data for PHIBRO ANIMAL HEALTH CORP (PAHC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
PHIBRO ANIMAL HEALTH CORP (PAHC) has a book value per share of $7.04, based on its most recent annual SEC filing.
No recent press releases.